What are the risks of fibrinolytic therapy?

Fibrinolytic therapy is often used to treat patients who are endangered from blood clots. It treats thrombosis or precipitation, increased the production of the patient of enzymes that break down the blood clots. While clots may in some cases pose a health risk, they are an essential part of the healing process and prevent a large amount of blood from cuts or ulcers. The main risk of fibrinolytic therapy is an increased risk of bleeding, but it is also possible for the patient to have serious side effects from the drugs used or suffer from life -threatening allergic reactions.

It is not possible for drugs used in this type of therapy to target only blood clots that pose a risk to the patient. The drugs as such decompose clots during the bloodstream. This may pose a significant risk to patients, as large amounts of blood may be lost if the clotting is disrupted. Disruption of clotting may be life -threatening, especially if the patown has administered a drug that also prevents formationNew blood clots, which is a common practice in fibrinolytic therapy.

Patients who have recently undergone surgery are particularly the risk of blood loss due to fibrinolytic therapy. Blood clots, which are formed after surgery, even a minor surgery, are essential for the patient to continue bleeding. Fibrinolytic therapy can dissolve these clots, reopen the wounds and cause significant blood loss.

is also risky for a patient who has a bleeding disorder to undergo fibrinolytic therapy. The stomach ulcers, organ diseases or internal bleeding can be impaired by fibrinolytic drugs. Patients with a history of stroke are also at risk of subsequent occurrence after taking these drugs.

with any medicines, including drugs for fibrinolytic therapy, there is always a risk that the patient may have a serious allnergic reaction. Symptoms of allergic reaction mOhou include sudden fever, dizziness, swelling, rash or shortness of breath. Extremely severe allergic reactions may cause the patient to go into an anaphylactic shock, which can lead to death if it is not treated. Fibrinolytic therapy is usually performed in a hospital environment, so anaphylaxis can be treated immediately.